Flortaucipir F18
( DrugBank: Flortaucipir / KEGG DRUG: Flortaucipir F 18 )
3 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
5 | Progressive supranuclear palsy | 1 |
7 | Corticobasal degeneration | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
127 | Frontotemporal lobar degeneration | 1 |
5. Progressive supranuclear palsy
Clinical trials : 93 / Drugs : 97 - (DrugBank : 33) / Drug target genes : 65 - Drug target pathways : 111
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
7. Corticobasal degeneration
Clinical trials : 25 / Drugs : 39 - (DrugBank : 15) / Drug target genes : 9 - Drug target pathways : 41
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
127. Frontotemporal lobar degeneration
Clinical trials : 123 / Drugs : 107 - (DrugBank : 33) / Drug target genes : 49 - Drug target pathways : 89
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|